STONEPINE CAPITAL MANAGEMENT, LLC – Cidara Therapeutics, Inc. Transaction History
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$0
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+28.53%
quarter
Cidara Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -208.44K shares | -102K | $0.63 | 0 |
| Q2 2022 | share | Decrease | -91.65% | -2.28M shares | -1.97M | $0.49 | 208.44K |
| Q1 2022 | share | Increase | +8.00% | 184.99K shares | -857K | $0.83 | 2.49M |
| Q4 2021 | share | Increase | +195.28% | 1.52M shares | 1.18M | $1.29 | 2.31M |
| Q3 2021 | share | Decrease | -35.37% | -428.46K shares | -693K | $2.24 | 782.81K |
| Q2 2021 | share | Increase | 0.00% | 1.21M shares | 2.44M | $2.02 | 1.21M |
| Q2 2020 | share | Decrease | -100.00% | -1.30M shares | -3.23M | $3.69 | 0 |
| Q1 2020 | share | Increase | 0.00% | 1.30M shares | 3.23M | $2.48 | 1.30M |
| Q4 2018 | share | Decrease | -100.00% | -656.14K shares | -2.88M | $2.35 | 0 |
| Q3 2018 | share | Increase | +54.20% | 230.61K shares | 674K | $4.4 | 656.14K |
| Q2 2018 | share | Increase | 0.00% | 425.53K shares | 2.21M | $5.2 | 425.53K |